Investing to solve
global challenges

Watch the movie

Why Summa?

As the population and economy are growing, and technology transforms society, we are faced with increasing challenges. These challenges, however, provide tremendous opportunities as making the world more future-proof require us to adopt new and innovative solutions.

Summa seeks to invest in and develop companies that provide these solutions. Through their products or services, these companies aim to reduce climate change, mitigate resource scarcity, improve education, health and well-being or provide sustainable energy sources.

About Summa

Summa at a glance

Sector

Private Equity

Established

2016

Market Position

Mid Cap

Funds

2

Assets under mgmt

14 SEKbn

Portfolio companies

13

Investment Strategy

Thematic

Employees

30

Recent highlights

Highlight from the AIM: Rebecca Henderson on reimagining capitalism

At our Annual Investor Meeting last week, we had the honor to have Rebecca Henderson as a special guest. She shared key insights from the book and also discussed with Reynir how capitalism needs to change to build a sustainable world. Rebecca also shared her reflections on Summa Equity’s approach and development.
Interview

Summa Equity acquires Sengenics

Summa Equity acquires a majority stake in Sengenics, a proteomics company with a unique technology for production of full-length, correctly folded and functional protein
Acquisition

SDG Impact Standards available now

The Standards are being designed to help businesses and investors make a positive contribution towards achieving the SDGs by 2030. Summa Equity is part of the Implementation Working Group.
SDG

Portfolio Development

EcoOnline expands its SaaS solutions by acquiring Airsweb - a leading provider of Environmental, Health and Safety software to large enterprise customers.
Fueling further growth

Portfolio Development

Olink Proteomics acquired Agrisera AB to accelerate production of dedicated antibodies for development of new immunoassays. .
Accelerate production of antibodies

Case Studies

Norsk Gjennvinning and Summa Equity case studies in Harvard MBA class “Reimagining Capitalism”, the course is now available as book...
Reimagining Capitalism
See more news

Newsletter

Stay up to date

Follow Summa Equity and our investments.
Share what we work on, how we do it and why we do it.

Banner_Rapport_Spread

Portfolio Report 2019

This year, we have further aligned our reporting with the norms defined by the Impact Management Project (IMP). This is part of our effort to continuously improve the clarity and quality of our portfolio report. While the norms are integrated into our screening process for new investments, we have in the portfolio report leveraged the IMP framework more clearly to improve our external stakeholder communication.

Download the report